Anti-SC6A1/ SLC6A1/ GABATHG monoclonal antibody

Anti-SC6A1/ SLC6A1/ GABATHG antibody for FACS & in-vivo assay

Target products collectionGo to SLC6A1/SLC6A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T62184-Ab-1/ GM-Tg-hg-T62184-Ab-2Anti-Human SLC6A1 monoclonal antibodyHuman
GM-Tg-rg-T62184-Ab-1/ GM-Tg-rg-T62184-Ab-2Anti-Rat SLC6A1 monoclonal antibodyRat
GM-Tg-mg-T62184-Ab-1/ GM-Tg-mg-T62184-Ab-2Anti-Mouse SLC6A1 monoclonal antibodyMouse
GM-Tg-cynog-T62184-Ab-1/ GM-Tg-cynog-T62184-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC6A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T62184-Ab-1/ GM-Tg-felg-T62184-Ab-2Anti-Feline SLC6A1 monoclonal antibodyFeline
GM-Tg-cang-T62184-Ab-1/ GM-Tg-cang-T62184-Ab-2Anti-Canine SLC6A1 monoclonal antibodyCanine
GM-Tg-bovg-T62184-Ab-1/ GM-Tg-bovg-T62184-Ab-2Anti-Bovine SLC6A1 monoclonal antibodyBovine
GM-Tg-equg-T62184-Ab-1/ GM-Tg-equg-T62184-Ab-2Anti-Equine SLC6A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T62184-Ab-1/ GM-Tg-hg-T62184-Ab-2; GM-Tg-rg-T62184-Ab-1/ GM-Tg-rg-T62184-Ab-2;
GM-Tg-mg-T62184-Ab-1/ GM-Tg-mg-T62184-Ab-2; GM-Tg-cynog-T62184-Ab-1/ GM-Tg-cynog-T62184-Ab-2;
GM-Tg-felg-T62184-Ab-1/ GM-Tg-felg-T62184-Ab-2; GM-Tg-cang-T62184-Ab-1/ GM-Tg-cang-T62184-Ab-2;
GM-Tg-bovg-T62184-Ab-1/ GM-Tg-bovg-T62184-Ab-2; GM-Tg-equg-T62184-Ab-1/ GM-Tg-equg-T62184-Ab-2
Products NameAnti-SLC6A1 monoclonal antibody
Formatmab
Target NameSLC6A1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC6A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SC6A1/ SLC6A1/ GABATHG VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP004008human SLC6A1 Lentivirus particle
    ORF Viral VectorpGMLP004008human SLC6A1 Lentivirus plasmid
    ORF Viral VectorpGMLPm004347mouse Slc6a1 Lentivirus plasmid
    ORF Viral VectorvGMLPm004347mouse Slc6a1 Lentivirus particle


    Target information

    Target IDGM-T62184
    Target NameSLC6A1
    Gene ID6529,232333,79212,696617,484655,101088066,407118,100051613
    Gene Symbol and SynonymsA730043E01,GABATHG,GABATR,Gabt,Gabt1,GAT-1,GAT1,hGAT-1,MAE,SLC6A1,XT-1,Xtrp1
    Uniprot AccessionP30531,P23978
    Uniprot Entry NameSC6A1_HUMAN,SC6A1_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000157103
    Target ClassificationN/A

    The target: SLC6A1, gene name: SLC6A1, also named as GABATHG, GABATR, GAT1, MAE. The protein encoded by this gene is a gamma-aminobutyric acid (GABA) transporter that localizes to the plasma membrane. The encoded protein removes GABA from the synaptic cleft, restoring it to presynaptic terminals. [provided by RefSeq, Jan 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.